Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Bluebird Bio (NQ: BLUE )

1.060 -0.060 (-5.36%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 10, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 6,870,213
Open 1.140
Bid (Size) 1.030 (117)
Ask (Size) 1.080 (245)
Prev. Close 1.120
Today's Range 1.020 - 1.160
52wk Range 0.8510 - 5.530
Shares Outstanding 67,578,549
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages bluebird bio Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - BLUE
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal Product Safety
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages bluebird bio Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - BLUE
WHY: NEW YORK, NY - (NewMediaWire) - May 10, 2024 - Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of bluebird bio, Inc. (NASDAQ: BLUE) between April 24, 2023 and... 
Via TheNewswire.com
Topics Lawsuit
Exposures Financial Legal Product Safety

Performance

YTD
-27.89%
-27.89%
1 Month
-10.92%
-10.92%
3 Month
+2.91%
+2.91%
6 Month
-64.43%
-64.43%
1 Year
-73.43%
-73.43%

More News

Read More
Stockholder Alert: Robbins LLP Reminds BLUE Investors of Upcoming May 28, 2024 Lead Plaintiff Deadline in the Bluebird Bio, Inc. Class Action
From Robbins LLP
Via GlobeNewswire
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
bluebird bio Reports First Quarter 2024 Results and Highlights Operational Progress and 2024 Guidance
From bluebird bio, Inc.
Via Business Wire
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages bluebird bio Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - BLUE
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal Product Safety
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages bluebird bio Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - BLUE
Via TheNewswire.com
Topics Lawsuit
Exposures Financial Legal Product Safety
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Blue
From Faruqi & Faruqi LLP
Via GlobeNewswire
SHAREHOLDER ACTION REMINDER: The Schall Law Firm Encourages Investors in bluebird bio, Inc. with Losses of $100,000 to Contact the Firm
From Schall Law
Via GlobeNewswire
bluebird bio Announces First Quarter 2024 Results Call Date and Upcoming Investor Events
From bluebird bio, Inc.
Via Business Wire
bluebird bio Announces Completion of First Cell Collection for LYFGENIA™ Gene Therapy
From bluebird bio, Inc.
Via Business Wire
ROSEN, TOP RANKED NATIONAL INVESTOR ATTORNEYS, Encourages bluebird bio Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - BLUE
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal Product Safety
ROSEN, TOP RANKED NATIONAL INVESTOR ATTORNEYS, Encourages bluebird bio Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - BLUE
Via TheNewswire.com
Topics Lawsuit
Exposures Financial Legal Product Safety
ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages bluebird bio Inc. Investors to Inquire About Securities Class Action Investigation - BLUE
Via NewMediaWire
Topics Regulatory Compliance
Exposures Legal Regulatory
ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages bluebird bio Inc. Investors to Inquire About Securities Class Action Investigation - BLUE
Via TheNewswire.com
Topics Regulatory Compliance
Exposures Legal Regulatory
ROSEN, A LEADING LAW FIRM, Encourages bluebird bio Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - BLUE
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal Product Safety
ROSEN, A LEADING LAW FIRM, Encourages bluebird bio Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - BLUE
Via TheNewswire.com
Topics Lawsuit
Exposures Financial Legal Product Safety
SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Blue
From Faruqi & Faruqi LLP
Via GlobeNewswire
ROSEN, A LEADING LAW FIRM, Encourages bluebird bio Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - BLUE
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal
ROSEN, A LEADING LAW FIRM, Encourages bluebird bio Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - BLUE
Via TheNewswire.com
Topics Lawsuit
Exposures Financial Legal
BLUE LOSS ALERT: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages bluebird bio Inc. Investors to Inquire About Securities Class Action Investigation – BLUE
From The Rosen Law Firm PA
Via GlobeNewswire
BLUEBIRD BIO, INC. (NASDAQ: BLUE) DEADLINE ALERT: Bernstein Liebhard LLP Reminds bluebird bio, Inc. Investors of Upcoming Deadline
From Bernstein Liebhard LLP
Via GlobeNewswire
ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages bluebird bio Inc. Investors to Inquire About Securities Class Action Investigation - BLUE
Via NewMediaWire
Topics Regulatory Compliance
Exposures Legal Regulatory
ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages bluebird bio Inc. Investors to Inquire About Securities Class Action Investigation - BLUE
Via TheNewswire.com
Topics Regulatory Compliance
Exposures Legal Regulatory
ROSEN, LEADING INVESTOR COUNSEL, Encourages bluebird bio Inc. Investors to Inquire About Securities Class Action Investigation – BLUE
From The Rosen Law Firm PA
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.